Quick navigation menu :

  1. Go to content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the help menu
  5. Go to the modules
  6. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Websites |
     
  4. Contact Us |
  5. Site map |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Your Health

Contact Us

Sanofi in Syria,
Damascus office:

Mezzeh – Opposite Jalaa’ Gymnasium
Damascus – Syria
P.O. Box 2861
Tel : +963 11 612 0766
Fax : +963 11 611 4914

Content :

Internal Medicine

Internal medicine is the practice of preventing and treating general diseases.

 

Very diverse diseases

  • Asthma is a chronic bronchial inflammation leading to an oedema and a narrowing of the airways and causing difficulty breathing.

  • Infection of the upper airways (sinusitis, amygdalitis/ pharyngitis) or the lower airways (bronchitis, community pneumonia) are the most frequent infectious diseases. The pathogenis agents Streptococcus pneumoniae and Haemophilus influenza are the causes of the most of these infectious diseases.

  • Rheumatiod arthritis is an autoimmune disease which mainly affects the tissues around joints. An immune reaction allows toxic mediators to penetrate the cells, leading to inflammation and granulation of cartilage and bone.

Frequent diseases

  • Asthma is now the most frequent chronic disease in childhood, affecting 1 out of 15 children.

  • Sixth global cause of mortality, community pneumonia is one of the most frequent and serious conditions.

  • Acute sinusitis in adults is also frequent: 1.4 adults in 1,000 every year in the United States.

  • Rheumatiod arthritis is the most frequent chronic inflammatory rheumatoid disorder in adults. It affects between 0.5 and 1% of the population. Onset is generally between 35 and 55 years. It is three to four times more frequent in women.

These diseases are crucial public health issues because they are the principle causes of global mortality. It is for that reason that Sanofi has concentrated its research efforts on those subjects for which the Group has developed world-renowned expertise.

Update: April 01, 2006